ARTICLE https://harbor-dev.pubfactory.com/view/journals/jnccn/12/5/article-p603.xml Managing the Fruits of Our Success 2019-01-04 https://harbor-dev.pubfactory.com/view/journals/jnccn/12/5/article-p605.xml Part 3: Abstracts From the NCCN 19th Annual Conference: Advancing the Standard of Cancer Care™ 2019-01-04 https://harbor-dev.pubfactory.com/view/journals/jnccn/12/5/article-p611.xml BRAFV600E -Mutant Melanoma Presenting With Cardiac Involvement 2019-01-04 https://harbor-dev.pubfactory.com/view/journals/jnccn/12/5/article-p621.xml Melanoma, Version 4.2014 2019-01-04 https://harbor-dev.pubfactory.com/view/journals/jnccn/12/5/article-p630.xml Survivorship: Sleep Disorders, Version 1.2014 2019-01-04 https://harbor-dev.pubfactory.com/view/journals/jnccn/12/5/article-p643.xml International Adaptations of NCCN Clinical Practice Guidelines in Oncology 2019-01-04 https://harbor-dev.pubfactory.com/view/journals/jnccn/12/5/article-p657.xml Should the ASCO/ASH Guidelines for the Use of Intravenous Iron in Cancer- and Chemotherapy-Induced Anemia Be Updated? 2019-01-04 https://harbor-dev.pubfactory.com/view/journals/jnccn/12/5/article-p665.xml Clinical Discussion of the Management of Anaplastic Oligodendroglioma/Oligoastrocytoma (Both Codeleted and Nondeleted) 2019-01-04 https://harbor-dev.pubfactory.com/view/journals/jnccn/12/5/article-p673.xml Patient Attitudes and Issues in Colon Cancer Screening 2019-01-04 https://harbor-dev.pubfactory.com/view/journals/jnccn/12/5/article-p686.xml Prostate Cancer, Version 2.2014 2019-01-04 https://harbor-dev.pubfactory.com/view/journals/jnccn/12/5/article-p719.xml Neuroendocrine Prostate Cancer: Subtypes, Biology, and Clinical Outcomes 2019-01-04 https://harbor-dev.pubfactory.com/view/journals/jnccn/12/5/article-p727.xml Intermittent Versus Continuous Androgen Deprivation Therapy 2019-01-04 https://harbor-dev.pubfactory.com/view/journals/jnccn/12/5/article-p735.xml Underserved Topics in Oncology: The Role of Physical Activity in Improving Quality of Life and Decreasing Recurrence Risk in Patients With Cancer 2019-01-04 https://harbor-dev.pubfactory.com/view/journals/jnccn/12/5/article-pxvi.xml NCCN News 2019-01-04 https://harbor-dev.pubfactory.com/view/journals/jnccn/12/5/article-pxxxvii.xml Oncology Research Program 2019-01-04 https://harbor-dev.pubfactory.com/view/journals/jnccn/12/5S/article-p743.xml Advancing the Standard of Cancer Care in 2014 2019-01-04 https://harbor-dev.pubfactory.com/view/journals/jnccn/12/5S/article-p745.xml The Affordable Care Act: Where Are We Now? An NCCN Roundtable 2019-01-04 https://harbor-dev.pubfactory.com/view/journals/jnccn/12/5S/article-p750.xml Genomic Analysis of Breast Cancer Heralds a Changing Treatment Paradigm 2019-01-04 https://harbor-dev.pubfactory.com/view/journals/jnccn/12/5S/article-p759.xml Treatment of Metastatic Breast Cancer 2019-01-04 https://harbor-dev.pubfactory.com/view/journals/jnccn/12/5S/article-p764.xml Advances in the Treatment of Non-Small Cell Lung Cancer 2019-01-04 https://harbor-dev.pubfactory.com/view/journals/jnccn/12/5S/article-p768.xml Point/Counterpoint: Early Detection of Prostate Cancer: Do the Benefits Outweigh the Consequences? 2019-01-04 https://harbor-dev.pubfactory.com/view/journals/jnccn/12/5S/article-p773.xml New Developments in the Treatment of Castration-Resistant Prostate Cancer 2019-01-04 https://harbor-dev.pubfactory.com/view/journals/jnccn/12/5S/article-p777.xml NCCN Roundtable: Talking to Children About Cancer 2019-01-04 https://harbor-dev.pubfactory.com/view/journals/jnccn/12/5S/article-p781.xml Optimizing Surveillance and Balancing Evidence With Patient Expectations 2019-01-04 https://harbor-dev.pubfactory.com/view/journals/jnccn/12/5S/article-p785.xml Agents Make “Preferred List” in Metastatic Melanoma 2019-01-04 https://harbor-dev.pubfactory.com/view/journals/jnccn/12/5S/article-p789.xml Optimal Treatment of Unresectable Nonmelanoma Skin Cancers 2019-01-04 https://harbor-dev.pubfactory.com/view/journals/jnccn/12/5S/article-p793.xml Targeted Agents: Management of Dermatologic Toxicities 2019-01-04 https://harbor-dev.pubfactory.com/view/journals/jnccn/12/5S/article-p797.xml Guidelines for NHL: Updates to the Management of Diffuse Large B-Cell Lymphoma and New Guidelines for Primary Cutaneous CD30+ T-Cell Lymphoproliferative Disorders and T-Cell Large Granular Lymphocytic Leukemia 2019-01-04 https://harbor-dev.pubfactory.com/view/journals/jnccn/12/5S/article-p801.xml Chronic Lymphocytic Leukemia: State of the Art and Beyond 2019-01-04 https://harbor-dev.pubfactory.com/view/journals/jnccn/12/5S/article-p808.xml Multiple Myeloma: Advances Reported in 2013 Are Useful in the Clinic 2019-01-04 https://harbor-dev.pubfactory.com/view/journals/jnccn/12/5S/article-p813.xml NCCN Bone Health Task Force: Key Recommendations 2019-01-04 https://harbor-dev.pubfactory.com/view/journals/jnccn/12/5S/article-p817.xml Monitoring Molecular Response to Tyrosine Kinase Therapy in Chronic Myelogenous Leukemia 2019-01-04 https://harbor-dev.pubfactory.com/view/journals/jnccn/12/5S/article-p821.xml Treatment Strategies for Myeloid Growth Factors and Intravenous Iron: When, What, and How? 2019-01-04 https://harbor-dev.pubfactory.com/view/journals/jnccn/12/5S/article-p825.xml NCCN Guidelines for Survivorship Expanded to Address Two Common Conditions 2019-01-04 https://harbor-dev.pubfactory.com/view/journals/jnccn/12/5S/article-p829.xml NCCN Increases the Emphasis on Genetic/Familial High-Risk Assessment in Colorectal Cancer 2019-01-04 https://harbor-dev.pubfactory.com/view/journals/jnccn/12/5S/article-p833.xml Common Controversies in the Management of Gallbladder Cancer 2019-01-04 https://harbor-dev.pubfactory.com/view/journals/jnccn/12/5S/article-p836.xml Don’t Neglect Cultural Diversity in Oncology Care 2019-01-04 https://harbor-dev.pubfactory.com/view/journals/jnccn/12/5S/article-p838.xml International Adaptation and Use of NCCN Guidelines 2019-01-04